Tailoring NK Cell Receptor-Ligand Interactions: an Art in Evolution

65k
Total downloads
335k
Total views and downloads

Download PDF Download EPUB

Articles

CORRECTION

Published on 08 Oct 2018

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

Stephan Kloess
Alessa Ede Valverde da Silva
Olaf Oberschmidt
Tanja Gardlowski
Nadine Matthies
Maulik Vyas
Lubomir Arseniev
Michael Heuser
Elke Pogge von Strandmann
Ulrike Köhl

doi 10.3389/fimmu.2018.02326

1,146 views

EDITORIAL

Published on 27 Feb 2018

Editorial: Tailoring NK Cell Receptor–Ligand Interactions: An Art in Evolution

Ulrike Koehl
Antoine Toubert
Gianfranco Pittari

doi 10.3389/fimmu.2018.00351

2,822 views
7 citations

REVIEW

Published on 07 Nov 2017

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs

Gianfranco Pittari
Luca Vago
Moreno Festuccia
Chiara Bonini
Deena Mudawi
Luisa Giaccone
Benedetto Bruno

doi 10.3389/fimmu.2017.01444

10,886 views
61 citations

ORIGINAL RESEARCH

Published on 24 Oct 2017

Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System

Aldi Pupuleku
Marcel Costa-García
Domènec Farré
Hartmut Hengel
Ana Angulo
Aura Muntasell
Miguel López-Botet

doi 10.3389/fimmu.2017.01317

12,824 views
22 citations

ORIGINAL RESEARCH

Published on 08 Sep 2017

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

Stephan Kloess
Alessa Ede Valverde da Silva
Olaf Oberschmidt
Tanja Gardlowski
Nadine Matthies
Maulik Vyas
Lubomir Arseniev
Michael Heuser
Elke Pogge von Strandmann
Ulrike Köhl

doi 10.3389/fimmu.2017.01100

2,924 views
8 citations

ORIGINAL RESEARCH

Published on 07 Aug 2017

In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients

Beatriz Sanchez-Correa
Juan M. Bergua
Alejandra Pera
Carmen Campos
Maria Jose Arcos
Helena Bañas
Esther Duran
Rafael Solana
Raquel Tarazona

doi 10.3389/fimmu.2017.00931

8,446 views
29 citations

ORIGINAL RESEARCH

Published on 24 Jul 2017

Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property

María Delso-Vallejo
Jutta Kollet
Ulrike Koehl
Volker Huppert

doi 10.3389/fimmu.2017.00854

7,379 views
6 citations

PERSPECTIVE

Published on 12 Jul 2017

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies

Erhard Hofer
Ulrike Koehl

doi 10.3389/fimmu.2017.00745

5,915 views
27 citations

PERSPECTIVE

Published on 12 Jun 2017

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers

Meriem Messaoudene
Alexandra Frazao
Pierre Jean Gavlovsky
Antoine Toubert
Nicolas Dulphy
Anne Caignard

doi 10.3389/fimmu.2017.00683

3,331 views
11 citations

ORIGINAL RESEARCH

Published on 12 Jun 2017

A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma

Juliane Wagner
Viktoria Pfannenstiel
Anja Waldmann
Judith W. J. Bergs
Boris Brill
Sabine Huenecke
Thomas Klingebiel
Franz Rödel
Christian J. Buchholz
2 more
Evelyn Ullrich

doi 10.3389/fimmu.2017.00676

24,601 views
85 citations

ORIGINAL RESEARCH

Published on 12 Jun 2017

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

Amy K. Erbe
Wei Wang
Patrick K. Reville
Lakeesha Carmichael
KyungMann Kim
Eneida A. Mendonca
Yiqiang Song
Jacquelyn A. Hank
Wendy B. London
10 more
Paul M. Sondel

doi 10.3389/fimmu.2017.00675

4,865 views
19 citations

MINI REVIEW

Published on 09 Jun 2017

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment

Olaf Oberschmidt
Stephan Kloess
Ulrike Koehl

doi 10.3389/fimmu.2017.00654

12,373 views
58 citations

Share on

Frontiers in Immunology

Alloimmunity and Transplantation

Impact

335kTopic views
262kArticle views
65kArticle downloads

View impact

Articles

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

Editorial: Tailoring NK Cell Receptor–Ligand Interactions: An Art in Evolution

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs

Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients

Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers

A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment

Frontiers in Immunology

Alloimmunity and Transplantation